Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06355453 · ClinicalTrials.gov registry record
Evaluation of the Goldcrest Patch Performance
A clinical trial, sponsored by GE Healthcare.
- Completed
- Registry status
- 38
- Enrollment target
NCT06355453 is a clinical trial that has completed, run by GE Healthcare. The registered enrollment target is 38 participants.
The verdict
NCT06355453 has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
The Novii Patch is an accessory to the Novii+ Pod that connects directly to the Novii+ Pod and contains the surface electrodes that attach to the abdomen. The primary objective is to collect Data on Skin Integrity and Patch Adhesion Quality From the Patch After 18 Hours of Wear. The secondary objective is to evaluate fetal monitoring on adult pregnant females greater than 32 weeks gestation and non-pregnant females to collect data on electrical fetal, maternal, and uterine activity.
Interventions
- DEVICE Goldcrest Patch and Three Patch Coupons
- DEVICE Goldcrest Patch and Novii Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2024-04-22 |
| Est. Completion | 2025-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06355453
The ClinicalTrials.gov registry entry for NCT06355453 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Goldcrest Patch and Three Patch Coupons is the first listed.
NCT06355453 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06355453 about?
NCT06355453 is a clinical study titled "Evaluation of the Goldcrest Patch Performance". The Novii Patch is an accessory to the Novii+ Pod that connects directly to the Novii+ Pod and contains the surface electrodes that attach to the abdomen. The primary objective is to collect Data on Skin Integrity and Patch Adhesion Quality From the Patch After 18 Hours of Wear. The secondary objec...
What is the current status of trial NCT06355453?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2024-04-22. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT06355453?
The interventions under investigation include: Goldcrest Patch and Three Patch Coupons (DEVICE), Goldcrest Patch and Novii Patch (DEVICE).
Who is sponsoring clinical trial NCT06355453?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.